Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Metagenomi (MGX) Change in Account Payables (2023 - 2025)

Metagenomi (MGX) has disclosed Change in Account Payables for 3 consecutive years, with $346000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Change in Account Payables rose 113.46% to $346000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $1.1 million, a 195.3% increase, with the full-year FY2025 number at $1.1 million, up 195.3% from a year prior.
  • Change in Account Payables was $346000.0 for Q4 2025 at Metagenomi, up from -$1.6 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $3.2 million in Q1 2024 to a low of -$2.6 million in Q4 2024.
  • A 3-year average of -$11333.3 and a median of -$98000.0 in 2024 define the central range for Change in Account Payables.
  • Peak YoY movement for Change in Account Payables: surged 162.16% in 2024, then tumbled 483.7% in 2025.
  • Metagenomi's Change in Account Payables stood at -$2.5 million in 2023, then fell by 1.86% to -$2.6 million in 2024, then soared by 113.46% to $346000.0 in 2025.
  • Per Business Quant, the three most recent readings for MGX's Change in Account Payables are $346000.0 (Q4 2025), -$1.6 million (Q3 2025), and $74000.0 (Q2 2025).